SEC Form 4/A · accession 0001192482-15-000321
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Charles Garner
Officer — CFO and Chief Business Officer
Period of report
Dec 17, 2014
Accepted (ET)
Jul 28, 2015 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.47 | Dec 17, 2014 | A | 23,000 | A | — | Dec 17, 2024 | Common Stock | 23,000 | 23,000 | D |
| Employee Stock Option (right to buy)F2,F3 | $2.47 | Jul 25, 2015 | A | 23,000 | A | — | Dec 17, 2024 | Common Stock | 23,000 | 23,000 | D |
Explanation of responses
- F1The option vests monthly in equal proportions over a period of four years beginning on December 17, 2014.
- F2Amended to reflect correct transaction date.
- F3The option was granted on December 17, 2014 and vests 30% upon satisfaction of certain performance conditions, and then monthly thereafter in equal proportions over a three-year period beginning on the date the performance conditions are satisfied. On July 25, 2015 the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria were met, resulting in vesting of 30% of the option and the beginning of the three-year monthly vesting period.